Our Sponsors

We are extremely grateful for the support that we have received and continue to receive to support our research efforts.

We would like to acknowledge the following sponsors:

• Bernard S. Aaron Fund
• Wiltse Philanthropic Funds
• Brandon C. Gromada Head and Neck Cancer Foundation
• Ride Cincinnati
• Center for Clinical and Translational Science and Training Pilot Award
• University of Cincinnati Cancer Center, Team Science Grant
• University of Cincinnati, Division of Hematology/Oncology HOTSA/HOPGA Pilot Grant
• University of Cincinnati, Department of Internal Medicine Faculty Pilot Project Grant
• University of Cincinnati, Department of Radiation Oncology
• National Institute of Health Clinical and Translational Science Award KL2 Training Grant TR001426
• National Institute of Health, T32 Pathways to Cancer Therapeutics Grant (T32 CA117846)
• National Institute of Health, U01 Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy (U01 CA267985)
• American Cancer Society (ACS), Research Scholars Grants (RSG-19-111-10-CCE and RSG-CCE-133750)
• United States Department of Veterans Affairs (VA)
• United States Department of Defense (W81XWH-17-1-0377)
• Caris Life Sciences
• Pharmaceutical Sponsors: Merck – Janssen – Bristol-Myers Squibb – Pyxis Oncology – AstraZeneca – GlaxoSmithKline (GSK) – Quest Diagnostics (Haystack MRD) – Naveris (NavDx)